Chuang-hong Lu
Guangxi Key Laboratory Of Precision Medicine In Cardio Cerebrovascular Diseases Control And Prevention, No.6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
YWHAZ-mediated metabolic reprogramming via HIF1A/LDHA signaling promotes pulmonary arterial remodelling.
Journal: Cell death discovery
Published: November 02, 2025
Metrnl ameliorates myocardial ischemia-reperfusion injury by activating AMPK-mediated M2 macrophage polarization.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 09, 2024
Identification and experimental verification of senescence-related gene signatures and molecular subtypes in idiopathic pulmonary arterial hypertension.
Journal: Scientific reports
Published: June 11, 2024
Y4 RNA fragments from cardiosphere-derived cells ameliorate diabetic myocardial ischemia‒reperfusion injury by inhibiting protein kinase C β-mediated macrophage polarization.
Journal: Cardiovascular diabetology
Published: March 24, 2024
Endothelial progenitor cell-derived extracellular vesicles: the world of potential prospects for the treatment of cardiovascular diseases.
Journal: Cell & bioscience
Published: October 16, 2023
HMGB1-RAGE axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte autophagy and apoptosis in diabetic mice.
Journal: Biological chemistry
Published: February 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026